DIMO realigns healthcare operations under ‘DIMO Healthcare’ identity with recent foray into pharmaceuticals

• Company recently acquired Mansel Ceylon (Private) Limited and Associated Laboratories (Private) Limited, expanding into pharmaceutical field

Diversified conglomerate DIMO, with its recent expansion into the pharmaceutical sector, has now realigned all its healthcare operations under the new identity of ‘DIMO Healthcare’.

DIMO has been at the forefront of the nation’s healthcare sector by providing state-of-the-art medical equipment in the fields of radiology, ophthalmology, neurology, cardiology and oncology for over seven decades. 

Adding more value to the country’s healthcare sector, DIMO expanded into healthcare devices, consumables, contrast mediums and most recently into pharmaceuticals.

Aligned with its strategic vision, the company recently acquired Mansel Ceylon (Private) Limited and Associated Laboratories (Private) Limited, expanding into the pharmaceutical field.

This recent acquisition enables DIMO Healthcare to offer over 250 pharmaceutical products that cover pain management, respiratory disorders, gastroenterology, liver diseases, antibiotics, endocrinology, cardiovascular antihistamine, vitamins and supplements, neurology, dermatology and psychiatric treatment from renowned pharmaceutical manufacturers such as Medochemie Ltd – Cyprus, Grifols Inc – USA, Hetero Ltd – India, PT.Harsen – Indonesia, HovidBhd – Malaysia, Geno Pharmaceuticals Ltd – India and Tabros Pharma (Pvt.) Ltd – Pakistan, just to name a few. 

The DIMO Healthcare pharmaceutical arm also consists of an islandwide distribution network facilitating easy access for medicine. 

DIMO Chairman and Managing Director Ranjith Pandithage said, “Under this bold new identity DIMO Healthcare, we aim to expand the horizons of Sri Lanka’s healthcare sector with our objective of building a healthier nation. Our strategic vision has given us opportunities to facilitate multiple spectrums of the healthcare sector and we are confident that it will play a significant role in fuelling the dreams and aspirations of the communities we serve, within our efforts in building a healthier nation.”

DIMO Executive Director Wijith Pushpawela, who also oversees the healthcare segment of the group, said, “DIMO has always led the way in providing the latest internationally renowned technology to the local healthcare sector. It is after much careful consideration that we chose consumables, devices, contrast mediums and pharmaceutical brands that would further enhance our reputation within the healthcare sector.”

DIMO Healthcare has been a leader in various areas of the medical equipment industry, including radiology, ophthalmology, critical care, cardiology, oncology, urology and neonatal care by offering products from world-renowned manufacturers such as Siemens Healthineers, Carl Zeiss, Draeger and more.

In terms of the implants segment, the company provides cardiac stents, X-ray accessories, mechanical heart valves, catheters and pacemakers from internationally reputed principals such as Boston Scientific, St. Jude and more. In the consumables and contrast mediums sector, the company provides medical printers, monitors, pressure indicators and accessories for neonatal care, critical care, anaesthesiology and immobilisation accessories for radiation therapy and diagnostics from Sony &Codonics. DIMO Healthcare is the largest provider of PET scanners, MRI scanners and operating microscopes in Sri Lanka, covering every part of the island. The radiology equipment such as MRI, CT and PET-CT scanners supplied by DIMO Healthcare serves 525,643 patients per annum, while the operating microscopes perform 213,000 surgeries and over 1.5mn diagnostic tests per year.

The company also has supplied Sri Lanka’s first Tomotherapy unit, bringing the latest technology to the country. DIMO Healthcare is equipped with an unparalleled aftersales service as the service aspect plays a crucial role for uninterrupted functionality of these medical equipment.